Generated by AI
Kyverna Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing cell therapies for autoimmune diseases. The company’s work centers on engineered T-cell therapies, including CAR T-cell and related cell therapy approaches designed to target the immune cells that drive severe autoimmune and inflammatory conditions. Its current programs span multiple therapeutic areas, with particular emphasis on rheumatology and neurology, alongside research efforts in other antibody-mediated and inflammatory diseases. Kyverna Therapeutics develops product candidates for conditions such as lupus nephritis, systemic sclerosis, myasthenia gravis, stiff person syndrome, multiple sclerosis, and inflammatory bowel disease. The company’s platform combines advanced cell engineering and synthetic biology to pursue more precise immune modulation than traditional broad immunosuppressive treatments. Headquartered in Emeryville, California, Kyverna Therapeutics plays a specialized role in the biotechnology market by advancing cell-based immunology therapies for serious unmet medical needs.
Website5980 Horton Street
Emeryville, CA, 94608
United States
The latest articles about KYTX.
EMERYVILLE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical immunology company pioneering transformative therapies for people with neurologic autoimmune diseases, today announced that company management will present at the Jefferies Global Healthcare Conference in London, United Kingdom on Thursday, November 19, 2026, at 10:00 am GMT. A live webcast of the presentation may be accessed via the Investors section of the Kyverna website at i
Kyverna Therapeutics advances Miv-cel for autoimmune diseases, but valuation, launch, and funding risks remain. Click here to read this analysis on KYTX.
Summary of Nov 18's posts. Generated by AI.
Summary of Sep 24's posts. Generated by AI.
Summary of Oct 27's posts. Generated by AI.
Investors talking about KYTX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.